JBIO - Jade Biosciences, Inc.
NEXT EARNINGS:
Mar 26, 2026
(in 29 days)
EPS Est: $-0.45
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.50
DETAILS
HIGH:
$28.00
LOW:
$25.00
MEDIAN:
$26.50
CONSENSUS:
$26.50
UPSIDE:
90.92%
Market Cap:
452.85M
Volume:
146,702
Avg Volume:
304,833
52 Week Range:
6.565-100.1
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.02
Last Dividend:
$2.40
Exchange:
NASDAQ
Country:
US
Employees:
50
IPO Date:
2025-04-29
EPS (TTM):
-85.26
P/E Ratio:
-1.09
Revenue (TTM):
N/A
Total Assets:
80.33M
Total Debt:
417,000
Cash & Equiv:
33.75M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-90.9%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-13 | $-0.48 | $-0.57 | +15.8% | — | — | — |
| 2025-08-13 | $-0.86 | $-0.43 | -100.0% | — | — | — |
| 2025-04-25 | $-0.09 | $-8.40 | +98.9% | — | — | — |
| 2025-03-27 | $-0.19 | $-0.19 | 0.0% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Net Income | (69.63M) | (75.52M) | (51.51M) | (22.96M) | (9.61M) |
| EPS | -85.26 | -100.38 | -73.67 | -32.96 | -14.00 |
| Total Assets | 80.33M | 127.42M | 135.30M | 175.36M | 4.71M |
| Total Debt | 417,000 | 675,000 | 1.09M | 574,000 | 0 |
| Cash & Equivalents | 33.75M | 23.49M | 22.40M | 54.20M | 4.57M |
| Operating Cash Flow | (71.20M) | (56.78M) | (39.12M) | (27.40M) | (7.86M) |
| Free Cash Flow | (71.20M) | (56.92M) | (39.32M) | (27.58M) | (7.86M) |
| FCF per Share | -87.18 | -75.66 | -56.23 | -39.54 | -11.27 |
| Book Value | 76.43M | 109.46M | 126.74M | 172.42M | 2.94M |
| Cash & ST Investments | 78.62M | 122.44M | 129.22M | 167.38M | 4.57M |
| ROC Equity | -0.91 | -0.69 | -0.41 | -0.13 | -3.27 |